CrushSCI.com
Journal Selection & Manuscript Polishing Services
DRUGS journal cover Medicine
Back to journal directory

Review Cycle Records

DRUGS

Springer SCIE Non-OA
2026 Emerging Zone 12025 CAS Zone 1 TOP2025 JCR Q1
112.9Average days
82Median days
7Fastest days
350Longest days
1362025 publications

Paper Review Records

All Paper Review Records

19 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

100 days

Small-Cell Lung Cancer: Biology, Translational Science and Clinical Innovation

AuthorsShrey Sindhwani; Miles Thomas; Kanika Gehlaut; Harveen Kaur; Waqas Haque; Aditya Juloori; Noura J. Choudhury

Affiliations1. Department of Medicine, University of Chicago, Chicago, USA; 2. Department of Radiation Oncology, Shri Ram Murti Smarak Institute of Medical Sciences, Bareilly, India; 3. Department of Radiation and Cellular Oncology, University of Chicago, Chicago, USA

Source PDF DOI Publisher page
21 days

Acoziborole: First Approval

AuthorsAisling McGuigan

Affiliations1. Springer Nature, Auckland 0754, New Zealand

Source PDF DOI Publisher page
48 days

DLL3-Targeted Strategies in Advanced Prostate Cancer: Current Evidence and Future Perspectives

AuthorsGiovanna Pecoraro; Alberto De Giorgi; Giulia Montelatici; Giuseppe Salfi; Hui-Ming Lin; Fabio Turco; Tarek Taha; Himisha Beltran; Johann de Bono; Rahul Raj Aggarwal; Gunhild von Amsberg; Markus Joerger; Martina Imbimbo; Ilaria Colombo; Silke Gillessen; Martino Pedrani

Affiliations1. Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland; 2. Institute of Oncology Research (IOR), Bellinzona, Switzerland; 3. Clinical and Translational Oncology, Scuola Superiore Meridionale, Naples, Italy; 4. Medical Oncology Department, Turin University, Turin, Italy; 5. Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 6. The Institute of Cancer Research, London, UK; 7. The Royal Marsden NHS Foundation Trust, London, UK; 8. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA; 9. Division of Clinical Studies, The Institute of Cancer Research, London, UK; 10. UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA; 11. University Cancer Center Hamburg and Martini-Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 12. Department of Medical Oncology and Hematology, Health Ostschweiz (HOCH), St Gallen, Switzerland; 13. Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland

Source PDF DOI Publisher page
152 days

Emerging Strategies Targeting the PI3K/AKT/mTOR Pathway in HR+/HER2– Advanced Breast Cancer

AuthorsLan Lei; Madison Canning; Elizabeth Sakach; Almeera Lateef; Larisa Kamga; Minaam Abid; Kevin Kalinsky; Shipra Gandhi

Affiliations1. Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, USA; 2. Department of Medicine, Emory University School of Medicine, Atlanta, USA; 3. Department of Internal Medicine, Shifa International Hospital, Islamabad, Pakistan

Source PDF DOI Publisher page
98 days

Balancing Act: The Dual Roles of BAFF in Systemic Lupus Erythematosus

AuthorsJhonatan Antonio Álvarez-Gómez; Daniel Appelgren; Tomas Walhelm; Ioannis Parodis; Christopher Sjöwall

Affiliations1. Division of Inflammation & Infection, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden; 2. Division of Diagnostics and Specialist Medicine, Department of Health, Medicine, and Caring Sciences, Linköping University, Linköping, Sweden; 3. Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, and Center for Molecular Medicine (CMM), Stockholm, Sweden; 4. Department of Rheumatology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden

Source PDF DOI Publisher page
201 days

Long-Acting Lipoglycopeptide Treatment of Invasive Gram-Positive Infections

AuthorsMadison E. Salam; Daniel B. Chastain; Douglas Fish; Andrés F. Henao-Martínez; Michal Krsak; Matthew Miller; Taylor Morrisette; Scott Mueller; Martin Krsak

Affiliations1. Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, USA; 2. Department of Pharmacy, UCHealth University of Colorado Hospital, Aurora, USA; 3. Department of Clinical & Administrative Pharmacy, University of Georgia College of Pharmacy, Augusta, USA; 4. Division of Infectious Diseases, University of Colorado School of Medicine, Aurora, USA; 5. Dolnooravska Nemocnica s Poliklinikou, Dolny Kubin, Slovakia; 6. Department of Pharmacy, Children’s Hospital Colorado, Aurora, USA; 7. Department of Clinical Pharmacy & Outcomes Sciences, Medical University of South Carolina College of Pharmacy, Charleston, USA; 8. Department of Pharmacy Services, Medical University of South Carolina Health, Charleston, USA; 9. Trillion Clinical and Research Customs, LLC., Denver, USA

Source PDF DOI Publisher page
97 days

Comparative Efficacy of Non-opioid Analgesic Drugs for Chronic Cancer Pain: A Bayesian Network Meta-analysis

AuthorsSebastiano Mercadante; Giovanbattista Vizzini; Alessio Lo Cascio

Affiliations1. Main Regional of Supportive/Palliative Care, La Maddalena Cancer Center, Palermo, Italy; 2. Technical Resources, La Maddalena Cancer Center, Palermo, Italy

Source PDF DOI Publisher page
22 days

Ecnoglutide: First Approvals

AuthorsMatt Shirley

Affiliations1. Springer Nature, Auckland, New Zealand

Source PDF DOI Publisher page
312 days

The Long Road to Long-Acting: What Oral PrEP and CAB-LA Teach Us About Scaling Lenacapavir

AuthorsVictor Abiola Adepoju; Abdulrakib Abdulrahim; Shankar Biswas

Affiliations1. Department of HIV and Infectious Diseases, Jhpiego Nigeria (An Affiliate of Johns Hopkins University), Abuja, Nigeria; 2. Department of Medical Microbiology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia; 3. Department of Internal Medicine, Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine

Source PDF DOI Publisher page
53 days

Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews

AuthorsGiancarlo De la Torre Canales; Marie-Amélie Dureisseix; Thiago Germano dos Santos; Pedro Miguel Teixeira Carvas Cebola; Glauce Crivelaro do Nascimento; Tatiana Foscaldo; Rodrigo Lorenzi Poluha; Justin Durham; Nikolaos Christidis

Affiliations1. Egas Moniz Interdisciplinary Research Centre (CiiEM), Egas Moniz School of Health and Sciences, Caparica, Portugal; 2. Newcastle Hospitals NHS Foundation Trust, Newcastle-Upon-Tyne, UK; 3. Department of Basic and Oral Biology, Faculty of Dentistry of Ribeirão Preto, University of São Paulo (USP), Ribeirão Preto, Brazil; 4. Orofacial Pain Unit, CUF Tejo Hospital, Lisbon, Portugal; 5. Postgraduate Program in Temporomandibular Disorders and Orofacial Pain, Kikuchi Institute, Pará, Brazil; 6. Department of Dentistry, State University of Maringá, Paraná, Brazil; 7. School of Dental Sciences, Framlington Place Newcastle University, Newcastle-Upon-Tyne, UK; 8. Division of Oral Rehabilitation, Department of Dental Medicine, Karolinska Institutet, Huddinge, Sweden

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.